Identification and utilization of genetic mutations in the treatment of ovarian cancer

被引：0
|
作者：
Johnson, A. [1 ]
Hawkins, G. M. [1 ]
Kouri, A. [1 ]
Clark, L. H. [1 ]
机构：
[1] Univ N Carolina, Chapel Hill, NC 27515 USA
来源：
GYNECOLOGIC ONCOLOGY | 2020年 / 159卷
关键词：
D O I：
10.1016/j.ygyno.2020.05.464
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
576
引用
收藏
页码：267 / 267
页数：1
相关论文
共 50 条
  • [31] Statistical neural networks and Support Vector Machine for the classification of genetic mutations in ovarian cancer
    Sehgal, MSB
    Gondal, L
    Dooley, L
    [J]. PROCEEDINGS OF THE 2004 IEEE SYMPOSIUM ON COMPUTATIONAL INTELLIGENCE IN BIOINFORMATICS AND COMPUTATIONAL BIOLOGY, 2004, : 140 - 146
  • [32] THE OVARIAN CANCER FAMILIAL CANCER CLINIC (OVFCC): A TREATMENT FOCUSED GENETIC ASSESSMENT AND TESTING OF SEROUS OVARIAN CANCER PATIENTS
    Antill, Y.
    Kentwell, M.
    Wrede, D.
    McNally, O. M.
    Sexton, A.
    Taylor, J.
    Bogwitz, M.
    Hodgkin, L.
    Mann, K.
    Beard, C.
    Higgs, E.
    Lindeman, G.
    Scott, C. L.
    [J]. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2014, 24 (09) : 481 - 481
  • [33] Identification of deleterious germline CHEK2 mutations and their association with breast and ovarian cancer
    Kleiblova, Petra
    Stolarova, Lenka
    Krizova, Katerina
    Lhota, Filip
    Hojny, Jan
    Zemankova, Petra
    Havranek, Ondrej
    Vocka, Michal
    Cerna, Marta
    Lhotova, Klara
    Borecka, Marianna
    Janatova, Marketa
    Soukupova, Jana
    Sevcik, Jan
    Zimovjanova, Martina
    Kotlas, Jaroslav
    Panczak, Ales
    Vesela, Kamila
    Cervenkova, Jana
    Schneiderova, Michaela
    Burocziova, Monika
    Burdova, Kamila
    Stranecky, Viktor
    Foretova, Lenka
    Machackova, Eva
    Tavandzis, Spiros
    Kmoch, Stanislav
    Macurek, Libor
    Kleibl, Zdenek
    [J]. INTERNATIONAL JOURNAL OF CANCER, 2019, 145 (07) : 1782 - 1797
  • [34] Tailoring Ovarian Cancer Treatment: Implications of BRCA1/2 Mutations
    Madariaga, Ainhoa
    Lheureux, Stephanie
    Oza, Amit M.
    [J]. CANCERS, 2019, 11 (03)
  • [35] Identification of a genetic variant associated with treatment outcome in ovarian cancer: the potential role of cholesterol metabolism as a determinant of response to chemotherapy
    Georgia Chenevix-Trench
    Yi Lu
    Sharon Johnatty
    Eric Gamazon
    Jonathan Beesley
    Xiaoqing Chen
    Bo Gao
    Paul Harnett
    R Stephanie Huang
    Evelyn Despierre
    Florian Heitz
    Estrid Hogdall
    Claus Hogdall
    Robert Brown
    Kirsten Moyisch
    Peter Fasching
    Ellen Goode
    Amanda Russell
    Michelle Henderson
    Michelle Haber
    Eileen Dolan
    Stuart Macgregor
    Anna deFazio
    [J]. Hereditary Cancer in Clinical Practice, 10 (Suppl 2)
  • [36] Identification of Genetic Mutations in Cancer: Challenge and Opportunity in the New Era of Targeted Therapy
    Jin, Jing
    Wu, Xu
    Yin, Jianhua
    Li, Mingxing
    Shen, Jing
    Li, Jing
    Zhao, Yueshui
    Zhao, Qijie
    Wu, Jingbo
    Wen, Qinglian
    Cho, Chi Hin
    Yi, Tao
    Xiao, Zhangang
    Qu, Liping
    [J]. FRONTIERS IN ONCOLOGY, 2019, 9
  • [37] The Value of Panel Testing for the Identification of Women with a Genetic Predispostion to Breast or Ovarian Cancer
    Tait, Jane
    Hipwell, Michael
    Mossman, David
    McPhillips, Mary
    Hall, Danielle
    Smits, Kira
    Ziolkowski, Andrew
    Scott, Rodney J.
    [J]. ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2019, 15 : 37 - 38
  • [38] CBP truncating mutations in ovarian cancer
    Ward, R
    Johnson, M
    Shridhar, V
    van Deursen, J
    Couch, FJ
    [J]. JOURNAL OF MEDICAL GENETICS, 2005, 42 (06) : 514 - 518
  • [39] Utilization of catastrophic autophagy in ovarian cancer
    Delaney, Joe R.
    Patel, Chandni
    Stupack, Dwayne G.
    [J]. CANCER RESEARCH, 2015, 75
  • [40] Treatment Decision Making and Genetic Testing for Breast Cancer Mainstreaming Mutations
    Katz, Steven J.
    Kurian, Allison W.
    Morrow, Monica
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2015, 314 (10): : 997 - 998
12345